Abstract
Parkinson disease (PD) and Alzheimer disease (AD) are neurodegenerative processes whose frequency is dramatically increasing in the western world.
Both diseases share a common pathogenic denominator characterized by an exaggerated activation of the systemic and cerebral immune system, respectively. For instance, lipopolysaccharides in PD and amyloid beta in AD trigger microglia and astrocytes to release reactive oxygen species (ROS) and proinflammatory cytokines. Infiltrating peripheral T cells once activated in the central nervous system also contribute to the neurodegenerative process.
Besides innovative biotherapy, nutraceuticals or functional foods are currently investigated for their neuroprotective activities. Especially, vitamin D and polyphenols, seem to be promising therapeutic tools for inhibiting ROS formation and arresting cytokine-mediated neuroinflammation in PD and AD.
Keywords: Alzheimer disease, immunity, neurodegeneration, nutraceuticals, Parkinson disease, lipopolysaccharides, astrocytes, dopamine, raphe nuclei, hyposmia
Current Pharmaceutical Design
Title: Immunopathogenesis of Neurodegenerative Diseases: Current Therapeutic Models of Neuroprotection with Special Reference to Natural Products
Volume: 18 Issue: 1
Author(s): T. Magrone, G. Marzulli and E. Jirillo
Affiliation:
Keywords: Alzheimer disease, immunity, neurodegeneration, nutraceuticals, Parkinson disease, lipopolysaccharides, astrocytes, dopamine, raphe nuclei, hyposmia
Abstract: Parkinson disease (PD) and Alzheimer disease (AD) are neurodegenerative processes whose frequency is dramatically increasing in the western world.
Both diseases share a common pathogenic denominator characterized by an exaggerated activation of the systemic and cerebral immune system, respectively. For instance, lipopolysaccharides in PD and amyloid beta in AD trigger microglia and astrocytes to release reactive oxygen species (ROS) and proinflammatory cytokines. Infiltrating peripheral T cells once activated in the central nervous system also contribute to the neurodegenerative process.
Besides innovative biotherapy, nutraceuticals or functional foods are currently investigated for their neuroprotective activities. Especially, vitamin D and polyphenols, seem to be promising therapeutic tools for inhibiting ROS formation and arresting cytokine-mediated neuroinflammation in PD and AD.
Export Options
About this article
Cite this article as:
Magrone T., Marzulli G. and Jirillo E., Immunopathogenesis of Neurodegenerative Diseases: Current Therapeutic Models of Neuroprotection with Special Reference to Natural Products, Current Pharmaceutical Design 2012; 18 (1) . https://dx.doi.org/10.2174/138161212798919057
DOI https://dx.doi.org/10.2174/138161212798919057 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies for In Vivo siRNA Delivery in Cancer
Mini-Reviews in Medicinal Chemistry HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development?
Protein & Peptide Letters Autoimmunity and Frontotemporal Dementia
Current Alzheimer Research Pharmacogenetics of Oral Anticoagulant Therapy
Current Pharmaceutical Design Progress Toward Understanding the Nature and Function of C-H...O Interactions
Current Organic Chemistry The Role of Minocycline in Ischemia-Reperfusion Injury: A Comprehensive Review of an Old Drug with New Implications
Recent Patents on Cardiovascular Drug Discovery Design, Synthesis and In-vivo Anti-inflammatory Activity of New Celecoxib Analogues as NSAID
Mini-Reviews in Medicinal Chemistry Critical Role for IL-15 in Innate Immunity
Current Molecular Medicine A QSAR Study on Some Series of Anti-Hepatitis C Virus (HCV) Agents
Letters in Drug Design & Discovery Chronic Tendon Pain-Implications for Treatment: An Update
Current Drug Targets Long Term Prognosis in IgG4-Related Systemic Disease (ISD)
Current Immunology Reviews (Discontinued) Protecting the Heart: Biological Targets and Clinical Strategies
Current Pharmaceutical Design Intrinsic Disorder in the Core Proteins of Flaviviruses
Protein & Peptide Letters Epigenetics: Relations to Disease and Laboratory Findings
Current Medicinal Chemistry Parvalbumin as a Pleomorphic Protein
Current Protein & Peptide Science Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
CNS & Neurological Disorders - Drug Targets MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers Nanovesicle Formulation Enhances Anti-inflammatory Property and Safe Use of Piroxicam
Pharmaceutical Nanotechnology Patent Selections:
Recent Patents on Anti-Infective Drug Discovery Transcription Factors Involved in Plant Resistance to Pathogens
Current Protein & Peptide Science